PMID- 30746867 OWN - NLM STAT- MEDLINE DCOM- 20200629 LR - 20200629 IS - 1934-1563 (Electronic) IS - 1934-1482 (Linking) VI - 11 IP - 7 DP - 2019 Jul TI - COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment. PG - 737-744 LID - 10.1002/pmrj.12125 [doi] AB - BACKGROUND: The Controlled Oral Word Association Test (COWAT) evaluates frontal lobe and executive function. Therefore, it can be helpful in differentiating cognitive deficits. However, there are no studies comparing the COWAT performance according to the type and stage of cognitive impairment. OBJECTIVE: To compare performance among persons with Alzheimer dementia (AD), vascular dementia (VaD), and Parkinson disease dementia (PDD) on the COWAT according to stage of cognitive impairment. DESIGN: Retrospective chart review. SETTINGS: University hospital rehabilitation psychology center. PATIENTS: We reviewed the medical records of 246 persons diagnosed with mild cognitive impairment (MCI) or dementia using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the Korean-Instrumental Activities of Daily Living (K-IADL). Patients were divided into a control group, Alzheimer groups (amnestic mild cognitive impairment [aMCI] + AD), Vascular groups (vascular mild cognitive impairment [VaMCI] + VaD), and Parkinson groups (Parkinson disease-mild cognitive impairment [PD-MCI] + PDD). METHODS: Total scores (ie, total number of words produced in 60 seconds on the semantic and phonemic fluency tests of the COWAT) were analyzed. Secondary analysis included calculating percentage scores of words produced during each of the four, 15-second segments from the total number of words produced in each trial. RESULTS: All MCI groups scored significantly lower than the control group on both semantic and phonemic fluency tests. Among the dementia groups, the VaD (mean +/- SD, 5.6 +/- 5.1) and PDD (5.5 +/- 5.5) groups' scores were significantly lower and worse than that of the AD (11.0 +/- 8.8) group on the phonemic test (P < .001). The difference in percentage scores was most marked between the PD-MCI (17.0 +/- 2.2) and PDD (1.2 +/- 3.1) groups, followed by the VaMCI (13.3 +/- 1.9) and VaD (5.6 +/- 1.8) groups on the latter phonemic test (P = .007). CONCLUSIONS: The COWAT is a sensitive test of frontal-lobe and executive function impairment in persons with MCI. Decreased verbal output in the last 15 seconds of phonemic fluency test is significantly decreased and impaired in persons with VaMCI and PD-MCI compared to persons with aMCI as they progress to dementia. LEVEL OF EVIDENCE: III. CI - (c) 2019 American Academy of Physical Medicine and Rehabilitation. FAU - Lim, Kil-Byung AU - Lim KB AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Kim, Jiyong AU - Kim J AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Lee, Hong-Jae AU - Lee HJ AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Yoo, Jeehyun AU - Yoo J AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Kim, Ha Seong AU - Kim HS AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Kim, Changgyu AU - Kim C AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. FAU - Lee, Hojin AU - Lee H AD - Department of Physical Medicine and Rehabilitation, Ilsan Paik Hospital, Inje University, Goyang, South Korea. LA - eng PT - Journal Article DEP - 20190507 PL - United States TA - PM R JT - PM & R : the journal of injury, function, and rehabilitation JID - 101491319 SB - IM MH - Aged MH - Alzheimer Disease/complications/*physiopathology MH - Cognition/*physiology MH - Cognitive Dysfunction/diagnosis/etiology/*physiopathology MH - Dementia, Vascular/complications/*physiopathology MH - Female MH - Follow-Up Studies MH - Frontal Lobe/*physiopathology MH - Humans MH - Male MH - *Neuropsychological Tests MH - Parkinson Disease/complications/*physiopathology MH - Reproducibility of Results MH - Retrospective Studies EDAT- 2019/02/13 06:00 MHDA- 2020/07/01 06:00 CRDT- 2019/02/13 06:00 PHST- 2018/08/23 00:00 [received] PHST- 2018/12/28 00:00 [accepted] PHST- 2019/02/13 06:00 [pubmed] PHST- 2020/07/01 06:00 [medline] PHST- 2019/02/13 06:00 [entrez] AID - 10.1002/pmrj.12125 [doi] PST - ppublish SO - PM R. 2019 Jul;11(7):737-744. doi: 10.1002/pmrj.12125. Epub 2019 May 7.